EGLN1 and renal cell carcinoma: The patients without disease recurrence or death from RCC also had a higher nuclear percentage of PHD2 compared to patients with disease recurrence or death from RCC (p = 0.001 in the Helsinki cohort and p = 0.028 in the Turku cohort, Mann–Whitney U‐test) as visualized in Figure S5.